blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1611896

EP1611896 - USE OF N-ACETYL-D-AMINOGLYCOSAMINE IN TREATMENT OF HYPERTHYROIDISM [Right-click to bookmark this link]
Former [2006/01]USE OF N-ACETYL-D-AMINOGLYCOSAMINE IN TREATMENT OF LOCAL LESIONS OR SYSTEMATIC SYMPTOMS RELATED TO AUTOIMMUNE REACTIONS
[2010/36]
StatusThe application is deemed to be withdrawn
Status updated on  08.04.2011
Database last updated on 28.09.2024
Most recent event   Tooltip08.04.2011Application deemed to be withdrawnpublished on 11.05.2011  [2011/19]
Applicant(s)For all designated states
Third Military Medical University Chinese People's Liberation Army P.R. of China
No. 30-Gaotanyan Street, Shapingba District
Chongqing 400038 / CN
For all designated states
Beijing Sino-Hongkong Dafu Science & Technology of Biowave Co., Ltd.
Room 102, Xiaoyuyang Hotel, North of Erhuan Road, Pinggu Town, Pinggu District
Beijing 101200 / CN
For all designated states
Bio-Wave Institute of Suzhou Hi-Tech New District Corporation, Ltd
5F No. 125-Binghe Street, New District of Suzhou
Jiangsu 215011 / CN
[2006/01]
Inventor(s)01 / XU, Qiwang
N0. 30 Gaotanyan Street, Shapingba District
Chongqing 400038 / CN
02 / LIU, Junkang
N0. 30 Gaotanyan Street, Shapingba District
Chongqing 400038 / CN
03 / YUAN, Zetao
NO. 30 Gaotanyan Street, Shapingba District
Chongqing 400038 / CN
 [2006/01]
Representative(s)Carpintero Lopez, Francisco, et al
Herrero & Asociados, S.L.
Agustín de Foxá, 4-10
28036 Madrid / ES
[N/P]
Former [2006/01]Carpintero Lopez, Francisco, et al
Herrero & Asociados, S.L., Alcalá, 35
28014 Madrid / ES
Application number, filing date04723965.229.03.2004
[2006/01]
WO2004CN00275
Priority number, dateCN2003100827727.03.2003         Original published format: CN 03108277
[2006/01]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2004084913
Date:07.10.2004
Language:EN
[2004/41]
Type: A1 Application with search report 
No.:EP1611896
Date:04.01.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 07.10.2004 takes the place of the publication of the European patent application.
[2006/01]
Search report(s)International search report - published on:CN07.10.2004
(Supplementary) European search report - dispatched on:EP04.07.2007
ClassificationIPC:A61P5/14, A61K31/7008
[2010/36]
CPC:
A61K31/7008 (EP,US); A61P25/04 (EP); A61P29/00 (EP);
A61P37/02 (EP); A61P37/06 (EP); A61P5/14 (EP)
Former IPC [2006/01]A61K31/7008, A61P37/06
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/01]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:VERWENDUNG VON N-ACETYL-D-AMINOGLYCOSAMIN BEI DER BEHANDLUNG VON HYPERTHYREOSE[2010/36]
English:USE OF N-ACETYL-D-AMINOGLYCOSAMINE IN TREATMENT OF HYPERTHYROIDISM[2010/36]
French:UTILISATION DE N-ACETYL-D-AMINOGLYCOSAMINE POUR LE TRAITEMENT DE L'HYPERTHYROÏDIE[2010/36]
Former [2006/01]VERWENDUNG VON N-ACETYL-D-AMINOGLYCOSAMIN BEI DER BEHANDLUNG VON LOKALEN LÄSIONEN ODER SYSTEMATISCHEN SYMPTOMEN IM ZUSAMMENHANG MIT AUTOIMMUNREAKTIONEN
Former [2006/01]USE OF N-ACETYL-D-AMINOGLYCOSAMINE IN TREATMENT OF LOCAL LESIONS OR SYSTEMATIC SYMPTOMS RELATED TO AUTOIMMUNE REACTIONS
Former [2006/01]UTILISATION DE N-ACETYL-D-AMINOGLYCOSAMINE POUR LE TRAITEMENT DE LESIONS LOCALES OU DE SYMPTOMES SYSTEMATIQUES ASSOCIES A DES REACTIONS AUTO-IMMUNES
Entry into regional phase17.10.2005Translation filed 
26.10.2005National basic fee paid 
26.10.2005Search fee paid 
26.10.2005Designation fee(s) paid 
26.10.2005Examination fee paid 
Examination procedure25.10.2004Request for preliminary examination filed
International Preliminary Examining Authority: CN
26.10.2005Examination requested  [2006/01]
13.11.2007Despatch of a communication from the examining division (Time limit: M04)
11.03.2008Reply to a communication from the examining division
28.07.2008Despatch of a communication from the examining division (Time limit: M04)
03.12.2008Reply to a communication from the examining division
14.08.2009Despatch of a communication from the examining division (Time limit: M02)
23.09.2009Reply to a communication from the examining division
07.09.2010Communication of intention to grant the patent
01.10.2010Application deemed to be withdrawn, date of legal effect  [2011/19]
08.11.2010Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2011/19]
Fees paidRenewal fee
10.03.2006Renewal fee patent year 03
29.03.2007Renewal fee patent year 04
11.03.2008Renewal fee patent year 05
18.03.2009Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.03.201007   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]EP0379753  (SPECK ULRICH) [Y] 4,7 * column 5, paragraph 1 *;
 [XY]WO03002117  (ASTION DEV AS [DK], et al) [X] 1-3,5,6 * examples 87,100,125 * * claims 1,4,5,39,40,47,70,71 * * page 34, line 30 * [Y] 4,7;
 [XY]WO03002125  (ASTION AS [DK], et al) [X] 1-3,5,6 * examples 45,87,88,273 * * claims 1,3,7,32,34,40,63,64 * [Y] 4,7;
 [L]  - MANNA R ET AL, "Psoriasis: an autoimmune disease", MINERVA MEDICA 1992 ITALY, (1992), vol. 83, no. 7-8, ISSN 0026-4806, pages 403 - 414, XP009085634 [L] 1-7 * the whole document *
International search[A]EP0372730  (UNIV BRITISH COLUMBIA [CA]);
 [X]US5217962  (BURTON ALBERT F [CA], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.